My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Transformers and Rectifiers gains after bagging order
Feb 28,2017

The announcement was made after market hours yesterday, 27 February 2017.

Meanwhile, the BSE Sensex was up 30.96 points, or 0.11%, to 28,843.84.

On the BSE, 2,524 shares were traded in the counter so far, compared with average daily volume of 12,792 shares in the past one quarter. The stock had hit a high of Rs 405.50 and a low of Rs 398.40 so far during the day. The stock had hit a 52-week high of Rs 471.85 on 20 January 2017. The stock had hit a 52-week low of Rs 196 on 29 February 2016.

Transformers and Rectifiers (India) (TRIL) said that it has bagged an order for supplying 39 transformers and reactors amounting to Rs 153 crore from Gujarat Energy Transmission Corporation (GETCO).

The order falls under the normal course of business. With the latest order, the companys order book now stands at around Rs 1020 crore.

TRIL manufactures a wide range of transformers for the domestic and the international market.

Powered by Capital Market - Live News

Goldstone Infratech jumps on big order for pure electric buses
Feb 27,2017

The announcement was made during market hours today, 27 February 2017.

Meanwhile, the S&P BSE Sensex was down 91.96 points or 0.32% at 28,801.01.

On the BSE, 66,000 shares were traded on the counter so far as against the average daily volumes of 50,967 shares in the past one quarter. The stock had hit a high of Rs 47.85 and a low of Rs 46.50 so far during the day.

The stock had hit a 52-week high of Rs 51.50 on 21 February 2017 and a 52-week low of Rs 15.45 on 28 March 2016. It had outperformed the market over the past one month till 23 February 2017, surging 61.7% compared with the Sensexs 6.55% rise. The scrip had also outperformed the market over the past one quarter, advancing 77.43% as against the Sensexs 10.91% rise.

The small-cap company has equity capital of Rs 14.43 crore. Face value per share is Rs 4.

Goldstone Infratech announced that it has bagged its second order for supply of twenty five pure electric buses to Himachal Road Transport Corporation (HRTC), Shimla, at a price of Rs 47.75 crore excluding AMC charges.

Goldstone has successfully completed trials of Midi electric bus in Manali-Rohtang pass. Goldstone shall be assembling these buses in India in tie up with BYD Auto, China. The bus will be designed in India and the bus body shall be fully built in India, the company said.

Goldstone Infratech had received its first order for supply of six pure electric buses to Brihan Mumbai Electricity Supply and Transport (BEST) undertaking, Mumbai.

Goldstone Infratechs net profit rose 35.6% to Rs 1.18 crore on 29.7% growth in net sales to Rs 23.35 crore in Q3 December 2016 over Q3 December 2015.

Goldstone Infratech is one of leading manufacturers for silicone rubber insulators for power transmission and distribution networks and supplies to large transmission & distribution companies and railways/metro rails in India and overseas.

Powered by Capital Market - Live News

Cadila Healthcare gains after receiving USFDA approval for anti viral drug
Feb 27,2017

The announcement was made during market hours today, 27 February 2017.

Meanwhile, the S&P BSE Sensex was down 22.92 points or 0.08% at 28,870.05.

On the BSE, 93,437 shares were traded on the counter so far as against the average daily volumes of 1.05 lakh shares in the past one quarter. The stock had hit a high of Rs 443 and a low of Rs 432.50 so far during the day. The stock had hit a record high of Rs 460 on 17 February 2017. The stock had hit a 52-week low of Rs 305 on 12 April 2016.

The stock had outperformed the market over the past one month till 23 February 2017, advancing 20.45% compared with the Sensexs 6.55% rise. The scrip had, however, underperformed the market over the past one quarter, gaining 9.69% as against the Sensexs 10.91% rise.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.

Cadila Healthcare announced that Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received final approval from the United States Food & Drug Administration (USFDA) to market Oseltamivir Phosphate Capsules, USP in strengths of 30mg, 45mg and 75mg.

The drug will be produced at the Nesher Pharmaceuticals USA manufacturing facility located at St. Louis, MO, USA. It is an anti viral used in the prevention and treatment of influenza virus infection. The estimated sales of capsules was $382 million as per IMS December 2016 data.

The group has also received the final approval from the USFDA to market Linezolid Tablets USP, 600 mg. The drug is an anti-bacterial agent used to treat certain serious bacterial infections and will be produced at the groups formulations manufacturing facility in the Pharma SEZ in Ahmedabad.

Cadila Healthcares consolidated net profit fell 34.6% to Rs 281.60 crore on 0.8% decrease in net sales to Rs 2249.60 crore in Q3 December 2016 over Q3 December 2015.

Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

Jubilant Life Sciences gains on USFDA nod for generic drug
Feb 27,2017

The announcement was made during market hours today, 27 February 2017.

Meanwhile, the S&P BSE Sensex was almost unchanged at 28,893.03.

On the BSE, 63,000 shares were traded on the counter so far as against the average daily volumes of 1.37 lakh shares in the past one quarter. The stock had hit a high of Rs 728 and a low of Rs 704 so far during the day.

The stock had hit a record high of Rs 765 on 7 February 2017 and a 52-week low of Rs 287.20 on 29 February 2016. It had underperformed the market over the past one month till 23 February 2017, gaining 4.7% compared with the Sensexs 6.55% rise. The scrip had also underperformed the market over the past one quarter, advancing 8.83% as against the Sensexs 10.91% rise.

The large-cap company has equity capital of Rs 15.93 crore. Face value per share is Rs 1.

ltraconazole Capsules, 100 mg, is the generic version of Sporanox of Janssen Pharmaceuticals, which is used for the treatment of fungal infections.

Jubilant Life Sciences has received 8 approvals from the United States Food and Drug Administration (USFDA) during the year. As on 31 December 2016, Jubilant Life Sciences had a total of 73 abbreviated new drug application (ANDAs) for oral solids filed in the US, of which 49 have been approved.

On a consolidated basis, Jubilant Life Sciences net profit fell 2.6% to Rs 119.78 crore on 8.7% growth in net sales to Rs 1438.81 crore in Q3 December 2016 over Q3 December 2015.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients and drug discovery solutions. The pharmaceuticals segment, through its wholly owned subsidiary Jubilant Pharma, is engaged in manufacture and supply of APIs, solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile and non-sterile products through 6 USFDA approved manufacturing facilities in India, USA and Canada.

The life science ingredients segment, is engaged in specialty intermediates, nutritional products and life science chemicals through 5 manufacturing facilities in India. The drug discovery solutions segment, provides proprietary in-house innovation & collaborative research and partnership for out-licensing through 3 world class research centres in India and USA.

Powered by Capital Market - Live News

Inox Leisure gains after starting operations of cinema theatre at Jamnagar
Feb 27,2017

The announcement was made on Saturday, 25 February 2017.

Meanwhile, the S&P BSE Sensex was up 29.74 points or 0.1% at 28,922.71.

On the BSE, 21,219 shares were traded in the counter so far as against average daily volume of 21,692 shares in the past one quarter. The stock had hit a high of Rs 246.95 and a low of Rs 237.15 so far during the day. The stock had hit a record high of Rs 292.90 on 2 September 2016. The stock had hit a 52-week low of Rs 184.15 on 29 February 2016.

The stock had underperformed the market over the past one month till 23 February 2017, falling 1.27% compared with the Sensexs 6.55% rise. The scrip had also underperformed the market over the past one quarter, gaining 6.18% as against the Sensexs 10.91% rise.

The small-cap company has equity capital of Rs 96.46 crore. Face value per share is Rs 10.

Inox Leisure said that the theatre taken on a lease basis is located at Jamnagar, Gujarat. The operations started with effect from 24 February 2017. The multiplex cinema theatre has 5 screens and 954 seats.

Inox Leisure is now present in 58 cities with 115 multiplexes, 454 screens and a total seating capacity of 1.15 lakh seats across India.

Inox Leisures consolidated net profit fell 78% to Rs 3.75 crore on 1.2% decline in net sales to Rs 279.22 crore in Q3 December 2016 over Q3 December 2015.

Inox Leisure is the diversification venture of the Inox group into entertainment.

Powered by Capital Market - Live News

Ruby Mills spurts after resuming operations at Khalapur unit
Feb 27,2017

The announcement was made on Friday, 24 February 2017. The stock market was closed on that day due to Mahashivratri holiday.

Meanwhile, the S&P BSE Sensex was up 12.99 points or 0.04% at 28,905.96.

On the BSE, 5,001 shares were traded on the counter so far as against the average daily volumes of 2,152 shares in the past one quarter. The stock had hit a high of Rs 365 and a low of Rs 350 so far during the day.

The stock had hit a 52-week high of Rs 518 on 28 September 2016 and a 52-week low of Rs 250.10 on 29 February 2016. It had underperformed the market over the past one month till 23 February 2017, sliding 1.12% compared with the Sensexs 6.55% rise. The scrip had, however, outperformed the market over the past one quarter, advancing 16.7% as against the Sensexs 10.91% rise.

The small-cap company has equity capital of Rs 8.36 crore. Face value per share is Rs 5.

Ruby Mills announced after market hours on Thursday, 23 February 2017 that the companys processing unit at Khalapur had got permission from Maharashtra Pollution Control Board (MPCB) to restart its operations with immediate effect. Earlier, the company had announced to the stock exchanges that the unit was experiencing disruption of operations due to power shut down by Maharashtra State Electricity Board (MSEB) on 7 February 2017, pursuant to MPCB instructions due to non-operation of common effluent treatment plant (CETP).

Ruby Mills net profit rose 23.3% to Rs 8.04 crore on 16.3% decline in net sales to Rs 41.12 crore in Q3 December 2016 over Q3 December 2015.

Ruby Mills is engaged in textiles business.

Powered by Capital Market - Live News

Lupin gains after Japanese subsidiary enters into agreement with Astellas
Feb 27,2017

The announcement was made during market hours today, 27 February 2017.

Meanwhile, the S&P BSE Sensex was up 9.07 points or 0.06% at 28,911.59.

On the BSE, 58,552 shares were traded on the counter so far as against the average daily volumes of 71,762 shares in the past one quarter. The stock had hit a high of Rs 1,465 and a low of Rs 1,450 so far during the day. The stock had hit a 52-week high of Rs 1,874.30 on 14 March 2016 and a 52-week low of Rs 1,294.05 on 29 March 2016.

The stock had underperformed the market over the past one month till 23 February 2017, falling 1.97% compared with the Sensexs 6.55% rise. The scrip had also underperformed the market over the past one quarter, dropping 2.28% as against the Sensexs 10.91% rise.

The large-cap company has equity capital of Rs 90.30 crore. Face value per share is Rs 2.

Lupin announced that its Japanese subsidiary Kyowa Pharmaceutical Industry Co., Ltd. and Astellas Pharma Inc. have entered into an agreement providing Kyowa the exclusive right to distribute and promote extended-release tablets of quetiapine fumarate in Japan.

Astellas submitted a new drug application (NDA) withthe Ministry of Health, Labour and Welfare in Japan for extended-release tablets of quetiapine fumarate for theindication of improvement of depressive symptoms associated with bipolar disorder.

When Astellas obtains an approval for the new drug application of extended-release tablets of Quetiapine fumarate, based on the agreement, Kyowa will exclusively distribute and promote the products in Japan, Lupin said.

Lupins consolidated net profit rose 20.7% to Rs 633.11 crore on 31.5% increase in net sales to Rs 4404.94 crore in Q3 December 2016 over Q3 December 2015.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally. The company is a significant player in the cardiovascular, diabetology, asthma, pediatric, CNS, GI, anti-infective and NSAID space and holds global leadership position in the anti-TB segment.

Powered by Capital Market - Live News

Gayatri Projects moves higher as JV completes power plant unit
Feb 27,2017

The announcement was made after market hours on Thursday, 23 February 2017. The stock market was shut on Friday, 24 February 2017 due to Mahashivratri holiday.

Meanwhile, the S&P BSE Sensex was up 19.01 points or 0.07% at 28,911.98.

On the BSE, 5,011 shares were traded on the counter so far as against the average daily volumes of 65,466 shares in the past one quarter. The stock had hit a high of Rs 142.70 and a low of Rs 139.05 so far during the day.

The stock had hit a record high of Rs 158 on 23 September 2016 and a 52-week low of Rs 99.75 on 29 March 2016. It had outperformed the market over the past one month till 23 February 2017, gaining 7.02% compared with the Sensexs 6.55% rise. The scrip had also outperformed the market over the past one quarter, advancing 13.2% as against the Sensexs 10.91% rise.

The small-cap company has equity capital of Rs 35.45 crore. Face value per share is Rs 2.

Gayatri Projects announced that its joint venture (JV) Sembcorp Gayatri Power has completed construction of its second 660-megawatts (MW) thermal power plant, marking the creation of 2,640 MW power complex.

The first unit of the 660 MW was completed in November 2016. The power plant, located in Krishnapatnam in Andhra Pradeshs SPSR Nellore District, utilises supercritical technology that allows for enhanced efficiency and reduced emissions.

Sembcorp Gayatri Power is a JV between Sembcorp Utilities, a subsidiary of Sembcorp Industries and NCC Infrastructure Holdings, which is promoted by NCC and Gayatri Energy Ventures, a wholly-owned subsidiary of Gayatri Projects.

Sembcorp Industries is a leading energy, water and marine group operating across five continents worldwide.

Gayatri Projects net profit rose 16.4% to Rs 14.16 crore on 23.4% growth in net sales to Rs 518.95 crore in Q3 December 2016 over Q3 December 2015.

Gayatri Projects in a Hyderabad-based infrastructure and construction company specializing in road, irrigation, power transmission and industrial projects with a pan India presence.

Powered by Capital Market - Live News

Lakshmi Vilas Bank advances after large bulk deal
Feb 27,2017

Meanwhile, the S&P BSE Sensex was up 5.82 points, or 0.02%, to 28,898.79.

Bulk deal boosted volume on the scrip. On the BSE, 39.94 lakh shares were traded on the counter so far as against the average daily volumes of 1.32 lakh shares in the past one quarter. The stock had hit a high of Rs 165 and a low of Rs 156.60 so far during the day.

The stock had hit a record high of Rs 168.70 on 23 September 2016 and a 52-week low of Rs 77.95 on 4 May 2016. The stock had outperformed the market over the past one month till 23 February 2017, advancing 13.91% compared with the Sensexs 6.55% rise. The scrip had also outperformed the market over the past one quarter advancing 14.28% as against the Sensexs 10.91% rise.

The mid-cap bank has equity capital of Rs 191.45 crore. Face value per share is Rs 10.

Lakshmi Vilas Banks net profit rose 70.1% to Rs 78.38 crore on 21.6% growth in total income of Rs 879.26 crore in Q3 December 2016 over Q3 December 2015.

Lakshmi Vilas Bank provides a variety of services, including corporate banking, commercial & personal banking, retail banking, NRI services, insurance and development banking through a network of branches.

Powered by Capital Market - Live News

TCS edges higher after winning contract
Feb 27,2017

The announcement was made after market hours on Thursday, 23 February 2017.

Meanwhile, the S&P BSE Sensex was up 17.39 points or 0.06% at 28,910.36.

On the BSE, 15,332 shares were traded on the counter so far as against the average daily volumes of 1 lakh shares in the past one quarter. The stock had hit a high of Rs 2,497 and a low of Rs 2,473.05 so far during the day. The stock had hit a 52-week high of Rs 2,740 on 16 August 2016 and a 52-week low of Rs 2,054.70 on 15 November 2016.

The stock had outperformed the market over the past one month till 23 February 2017, advancing 7.63% compared with the Sensexs 6.55% rise. The scrip had also outperformed the market over the past one quarter, gaining 15.07% as against the Sensexs 10.91% rise.

The large-cap company has equity capital of Rs 197.04 crore. Face value per share is Re 1.

TCS announced that Community Savings Bank Association (CSBA) has selected TCS BaNCS on the Cloud as the core banking solution for its member banks across the entire United Kingdom. CSBA is a co-operative society.

The vision of CSBA is to have a local network of customer owned, regional banks that create and support wealth creation in local communities. TCS BaNCS on the Cloud is a digital banking solution designed to meet the market requirements in the UK.

On a consolidated basis, TCS net profit rose 3.20% to Rs 6814 crore on 1.54% increase in net sales to Rs 29735 crore in Q3 December 2016 over Q2 September 2016.

TCS is an IT services, consulting and business solutions organization.

Powered by Capital Market - Live News

RIL jumps on reports of brokerage upgrade
Feb 27,2017

Meanwhile, the S&P BSE Sensex was almost unchanged at 28,894.39.

On the BSE, 7.43 lakh shares were traded on the counter so far as against the average daily volumes of 3.42 lakh shares in the past one quarter. The stock had hit a high of Rs 1,256.50 so far during the day, which is a 52-week high for the counter. The stock hit a low of Rs 1,187 so far during the day.

The stock had hit a 52-week low of Rs 925.70 on 23 May 2016. It had outperformed the market over the past one month till 23 February 2017, gaining 16.4% compared with the Sensexs 6.55% rise. The scrip had also outperformed the market over the past one quarter, advancing 17.41% as against the Sensexs 10.91% rise.

The large-cap company has equity capital of Rs 3243.86 crore. Face value per share is Rs 10.

The target price of Rs 1,506 per share is at a premium of 21.1% over the stocks ruling market price.

Shares of Reliance Industries (RIL) had rallied 10.97% in a single trading session on 22 February 2017, amid investors expectations of revenue generation from its telecom subsidiary Reliance Jio Infocomm (RJIL) starting from 1 April 2017. RIL at the fag end of market hours on 21 February 2017 said that it has breached the 100 million customer mark in 170 days.

RJIL announced that in addition to its own market leading tariff plans, it will also offer its customers the option to choose the highest selling tariff plan of any of the other leading Indian telecom operators, but with 20% more data than what any other operator provides.

RJIL had said that the existing 100 million plus Jio subscribers can avail of the special Jio Prime Membership programme which comes with several special benefits. The Jio Prime Membership is available only for existing Jio customers and the enrolment window will remain open from 1-31 March 2017.

RILs consolidated net profit rose 3.6% to Rs 7506 crore on 17.6% growth in net sales to Rs 79408 crore in Q3 December 2016 over Q3 December 2015.

Reliance Industries (RIL) is Indias largest private sector company. RILs activities span hydrocarbon exploration and production, petroleum refining and marketing, petrochemicals, retail and telecommunications.

Powered by Capital Market - Live News

GMR Infra jumps after completing strategic debt restructuring of subsidiary
Feb 27,2017

The announcement was made before market hours today, 27 February 2017.

Meanwhile, the BSE Sensex was up 38.64 points, or 0.13%, to 28,931.61.

On the BSE, 12.68 lakh shares were traded in the counter so far, compared with average daily volume of 10.41 lakh shares in the past one quarter. The stock had hit a high of Rs 15.95 in intraday trade, which is also a 52-week high for the stock. The stock had hit a low of Rs 14.91 so far during the day. The stock had hit a 52-week low of Rs 10.25 on 9 November 2016.

The stock had outperformed the market over the past one month till 23 February 2017, advancing 17.72% compared with the Sensexs 6.55% rise. The scrip had also outperformed the market over the past one quarter, gaining 32.74% as against the Sensexs 10.91% rise.

The mid-cap company has equity capital of Rs 603.59 crore. Face value per share is Re 1.

GMR Chhattisgarh Energy (GCEL), a subsidiary of GMR Infrastructure (GIL) has announced that the consortium of lenders of GCEL have adopted strategic debt restructuring plan (SDR), as provided under the scheme permitted by the Reserve Bank of India (RBI). Accordingly, GCEL has allotted equity shares to all the lenders.

As per the SDR scheme, out of the total outstanding debt (including accrued interest) of Rs 8800 crore, debt to the extent of Rs 2992 crore has been converted into equity by which the consortium lenders would have 52.4% shareholding and balance 47.6% would be held by GMR.

Post the conversion, the balance project debt stands at Rs 5800 crore with Rs 2992 crore equity held by lenders and Rs 2721 crore equity held by GMR Group, resulting in the debt-to-equity ratio of 1.0x. The lower debt levels would result in improving the long term viability of the project.

GCEL is a 1,370 megawatts (MW) (2x685 MW) coal based power plant at Tilda, Raipur, Chhattisgarh. The project was fully commissioned in March 2016 and has long term fuel security in the form of two captive coal blocks. The plant is currently operating under short term power purchase agreements (PPAs) through exchange and bilateral routes.

GMR Group is a leading global infrastructure conglomerate with interests in airport, energy, transportation and urban infrastructure. The group has fifteen power generation projects, nine operating road assets and a double rail track line of eastern dedicated freight corridor under development.

Powered by Capital Market - Live News

Castex Technologies jumps after boards nod for debt restructuring
Feb 27,2017

The announcement was made on Saturday, 25 February 2017.

Meanwhile, the S&P BSE Sensex was up 36.05 points or 0.12% at 28,929.02.

On the BSE, 6.30 lakh shares were traded on the counter so far as against the average daily volumes of 3.14 lakh shares in the past one quarter. The stock had hit a high of Rs 9.98 and a low of Rs 9.21 so far during the day.

The stock had hit a 52-week high of Rs 16.87 on 27 July 2016 and a 52-week low of Rs 4.77 on 8 April 2016. It had outperformed the market over the past one month till 23 February 2017, surging 10.86% compared with the Sensexs 6.55% rise. The scrip had also outperformed the market over the past one quarter, advancing 20.38% as against the Sensexs 10.91% rise.

The small-cap company has equity capital of Rs 75.62 crore. Face value per share is Rs 2.

Castex Technologies board at its meeting held on Saturday, 25 February 2017, approved the issuance of 3.9 crore equity shares of Rs 2 each at a premium of Rs 13 each aggregating to Rs 58.50 crore by way of preferential issue to promoters of the company upon conversion of their outstanding unsecured loans to the company.

The board also approved to issue upto 4 crore convertible warrants worth at a price of Rs 15 each aggregating to Rs 60 crore convertible into equal number of equity shares of Rs 2 each at a premium of Rs 13 each by way of preferential issue to promoters of the company upon conversion of their outstanding unsecured loans to the company.

The aforesaid proposals, if approved by the lenders, will lead to the change in the capital structure of the company resulting in significant dilution to the stake held by the existing promoters of the company. This will also lead to the change in control and management of the company.

Promoters held 46.86% stake in Castex Technologies end December 2016.

Castex Technologies reported a net loss of Rs 132.68 crore in the quarter ended December 2016, compared with net loss of Rs 141.30 crore in the quarter ended December 2015. Net sales declined 33.7% to Rs 338.08 crore in the quarter ended December 2016 over the quarter ended December 2015.

Castex Technologies (formerly known as Amtek India) is a leading provider of iron cast automotive components in India.

Powered by Capital Market - Live News

Eveready Industries moves higher after commencing operation at Assam plant
Feb 27,2017

The announcement was made on Friday, 24 February 2017, when the stock markets had remained closed on account of local holiday.

Meanwhile, the S&P BSE Sensex was up 20.89 points, or 0.07%, to 28,913.86.

On the BSE, 3,350 shares were traded on the counter so far as against the average daily volumes of 8,607 shares in the past one quarter. The stock had hit a high of Rs 256 and a low of Rs 251.50 so far during the day.

The stock had hit a 52-week high of Rs 291 on 30 August 2016 and a 52-week low of Rs 190 on 29 December 2016. The stock had underperformed the market over the past one month till 23 February 2017, advancing 5.09% compared with the Sensexs 6.55% rise. The scrip had, however, outperformed the market over the past one quarter advancing 14.9% as against the Sensexs 10.91% rise.

The small-cap company has equity capital of Rs 36.34 crore. Face value per share is Rs 5.

Eveready Industries India announced that the company has on 23 February 2017 commenced commercial production with a capacity of 500 million of batteries and 9 million LED flashlights per annum at its new unit at Industrial Growth Centre, Assam.

Eveready Industries India net profit rose 65.4% to Rs 35.19 crore on 1.7% increase in net sales to Rs 329.31 crore in Q3 December 2016 over Q3 December 2015.

Eveready Industries India is the market leader of dry cell batteries. Apart from dry cell batteries, the company is also the market leader in flashlights. Eveready also markets LED, CFL, GLS lamps & other lighting products and rechargeable lanterns & devices, and packet tea.

Powered by Capital Market - Live News

Kothari Products advances after divesting entire stake in subsidiary
Feb 27,2017

The announcement was made on Saturday, 25 February 2017.

Meanwhile, the BSE Sensex was up 49.32 points, or 0.17%, to 28,942.29.

On the BSE, 80 shares were traded in the counter so far, compared with an average volume of 4,626 shares in the past two weeks. The stock had hit a high of Rs 184 and a low of Rs 181.50 so far during the day. The stock had hit a 52-week high of Rs 235.30 on 26 October 2016. The stock had hit a 52-week low of Rs 146 on 20 March 2016.

The stock had underperformed the market over the past one month till 23 February 2017, advancing 3.87% compared with the Sensexs 6.55% rise. The scrip had also underperformed the market over the past one quarter, gaining 10.09% as against the Sensexs 10.91% rise.

The small-cap company has equity capital of Rs 29.84 crore. Face value per share is Rs 10.

Kothari Products net profit fell 25.3% to Rs 10.68 crore on 14.7% rise in net sales to Rs 1098.64 crore in Q3 December 2016 over Q3 December 2015.

Kothari Products, a flagship company of Kothari Group was incorporated on 17th September 1983 and has presence in real estate, investments and international trading of exports & imports.

Powered by Capital Market - Live News